[Form 4] Okta, Inc. Insider Trading Activity
Eric R. Kelleher, President and Chief Operating Officer of Okta, Inc. (OKTA), reported insider sales executed under a Rule 10b5-1 trading plan adopted April 15, 2025. On 09/18/2025 the reporting person sold 600 shares at a weighted average price of $91.2017, 5,304 shares at a weighted average price of $92.3001, and 2,618 shares at a weighted average price of $93.5885. The Form 4 shows the beneficial ownership amounts after those transactions as 17,096; 11,792; and 9,174 shares respectively. The filing also discloses outstanding restricted stock units totaling 103,129 shares and several fully vested employee stock options exercisable into Class A and Class B common stock.
- Sales executed under a documented Rule 10b5-1 trading plan, indicating pre-planned dispositions rather than ad-hoc insider trading
- Detailed disclosure of weighted-average prices and price ranges for the multiple sale tranches, enhancing transparency
- Significant remaining equity exposure: 103,129 restricted stock units and multiple vested options remain outstanding
- Insider sold 8,522 shares on 09/18/2025, which may be viewed negatively by some investors despite being pre-planned
- Form lines show reduced beneficial ownership per reported class after the transactions (17,096; 11,792; 9,174 shown)
Insights
TL;DR: Insider executed pre-planned sales totaling 8,522 shares under a 10b5-1 plan; substantial remaining equity and option/R SU holdings remain.
The transactions reported on Form 4 were effected pursuant to a 10b5-1 plan, which indicates pre-scheduled dispositions rather than ad-hoc sales. The filing lists three separate non-derivative dispositions on 09/18/2025 totaling 8,522 shares sold at weighted average prices between $91.20 and $93.59. Post-transaction beneficial ownership lines are provided for each class shown. Material additional equity exposure remains via 103,129 restricted stock units and multiple fully vested employee stock options across different strike prices and expirations, preserving continued alignment with company performance.
TL;DR: Sales were executed under an established 10b5-1 plan and the filing provides standard transparency on holdings and vesting schedules.
The Form 4 discloses that the reporting person adopted a Rule 10b5-1 trading plan on April 15, 2025, and that the reported disposals occurred pursuant to that plan. The filing includes clear vesting schedules for multiple RSU awards and confirms certain stock options are fully vested and exercisable. The presence of an attorney-in-fact signature is documented, and explanatory footnotes detail weighted-average price ranges and vesting terms, consistent with thorough insider disclosure practices.